Net clinical benefit outcome should be standardized in trials evaluating antithrombotic drugs : the example of NOACs in atrial fibrillation

Caldeira, DanielCosta, JoãoFerreira, Joaquim JPinto, Fausto J.2018-08-222018-08-222014-06-15Int J Cardiol. 2014 Jun 15;174(2):405-60167-5273http://hdl.handle.net/10451/34521© 2014 Elsevier Ireland Ltd. All rights reserved.engNet clinical benefitApixabanDabigatranEdoxabanRivaroxabanSafetyNet clinical benefit outcome should be standardized in trials evaluating antithrombotic drugs : the example of NOACs in atrial fibrillationjournal article10.1016/j.ijcard.2014.04.051